Home/ Supplements/ Vitamin K/ Osteo-Nutrients II (with Vitamin K2-7)

Osteo-Nutrients II (with Vitamin K2-7)

product on market Capsule Vital Nutrients Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 43% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Vitamin D3, K2, calcium, and magnesium are supported by strong evidence for maintaining bone density and mineral absorption. Horsetail powder provides silica, though research on its efficacy for bone health is more limited. Together, these ingredients target skeletal support through synergistic nutrient delivery.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Osteo-Nutrients II (with Vitamin K2-7)
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
120
Servings
Other Combinations
Product Type
43%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

12.5 mcg (63% DV)
Within RDA (0.8× RDA) 608 studies (A:16, B:251)
25 mcg (21% DV)
Within RDA (0.2× RDA) 275 studies (A:9, B:175)
Calcium
500 mg (38% DV)
250 mg (60% DV)
Within RDA (0.6× RDA) 316 studies (A:8, B:159)
Horsetail powder
50 mg
Market median: 500.0mg (159 products)
1.5 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews

Other Ingredients

Cellulose Magnesium Silicate Leucine
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Warnings & Precautions

Keep out of reach of children

Use only if safety seal is intact

Warning If you take Coumadin (warfarin) or other prescription blood thinners or are pregnant or nursing, consult your physician before taking.

Formulation Notes

Excludes coatings, binders, gluten (wheat, rye, barley), milk/dairy (casein, whey), soy protein, egg protein, sugar. Verified by independent testing

Raw materials and finished products are independently tested by U.S. labs.

Additional Information

Store sealed in a cool dry place

Recommendations 1 to 2 capsules 2 times daily with food, or as directed by your healthcare professional.

Learn more at vitalnutrients.net

Metadata

Product Details

UPC / SKU6 93465 31111 0
DSLD Entry Date2024-01-24
Product TypeOther Combinations
FormCapsule
DSLD ID305133
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.